Skip to content

Rybelsus

Also called oral semaglutide, Rybelsus tablet.

By Dr Chad Okay3 min read

Rybelsus is the brand name Novo Nordisk uses for oral semaglutide tablets, taken once a day for type 2 diabetes. It is the same molecule as injected Ozempic and Wegovy, but in pill form. The dosing rules are strict because semaglutide is hard to absorb through the gut. It is not currently licensed for weight loss.

Why a tablet is unusual

Most peptide drugs (like insulin and the original GLP-1 agonists) get destroyed in the stomach before they can be absorbed. Rybelsus solves this by combining semaglutide with a tiny amount of an absorption enhancer (SNAC) that briefly opens the stomach lining wide enough for the drug to pass through. It is the first oral GLP-1 drug to make it to market.

How to take it (the rules really matter)

  1. Take it on an empty stomach, first thing in the morning.
  2. Swallow whole with no more than a sip of water (about 120 ml).
  3. Wait at least 30 minutes before any food, drink, or other medication.
  4. Do not split, crush, or chew the tablet.
  5. If you skip the rules, absorption drops dramatically and the drug barely works.

Doses

  • Week 1 to 4: 3 mg daily. Starter dose, mostly for tolerance.
  • Week 5 to 8: 7 mg daily. First meaningful dose.
  • Week 9 onwards: 14 mg daily, the maintenance dose.
  • A 25 mg oral semaglutide dose was FDA-approved in December 2025 as the Wegovy pill for chronic weight management, same molecule, different brand and indication (OASIS-4 reported 16.6% mean weight loss in adherent participants at 64 weeks; the overall treatment-policy result was 13.6%).

Side effects

  • Nausea: common, especially after dose increases.
  • Diarrhoea or constipation: both reported, depending on the person.
  • Reflux and burping.
  • Loss of appetite (the intended effect).
  • Rare but serious: pancreatitis, gallstones, severe gastroparesis. Severe, persistent abdominal pain needs a doctor the same day, not a wait-and-see approach (see below).

Rybelsus vs Ozempic

Same drug. Different route. Injected Ozempic produces slightly more consistent blood levels because absorption isn't dependent on whether you took the tablet correctly. Both are licensed for type 2 diabetes only. Some people prefer the daily tablet over a weekly injection. Others prefer set-and-forget weekly dosing because the absorption rules around Rybelsus are easy to forget on a busy morning.

If something feels wrong

This entry is reference information, not medical guidance. Your doctor and pharmacist know you and your medicine; if anything about how you feel worries you, speak to them promptly, and if you ever feel seriously unwell, treat it as an emergency. The medicine's own patient information leaflet carries the important safety information and is worth reading in full.

Common questions

Not directly. Rybelsus the brand is licensed only for type 2 diabetes. The 14 mg dose produces modest weight loss but less than injected Wegovy. A higher 25 mg oral semaglutide dose was FDA-approved in December 2025 as the Wegovy pill for chronic weight management, same molecule, different brand and indication (OASIS-4 reported 16.6% mean weight loss in adherent participants at 64 weeks, 13.6% across all participants).

Built for this.

Suna is a wearable designed to help you see your own everyday patterns, without keeping a diary. Reservations open.

Sources

  1. 1RYBELSUS (oral semaglutide) US prescribing information - indications, dosage/administration, warningsDailyMed (US NLM) / Novo Nordisk label
  2. 2Rybelsus EPAR public assessment report (EU) - SNAC co-formulation, empty-stomach administration, 3/7/14 mg strengths, type 2 diabetes indicationEuropean Medicines Agency
  3. 3Oral semaglutide, first oral GLP-1 receptor agonist (Rybelsus) - review of SNAC absorption mechanism and PIONEER programmePubMed (Therapie, 2021)
  4. 4Wegovy pill approved in the US as first oral GLP-1 for weight management (oral semaglutide 25 mg, 22 December 2025, OASIS 4)Novo Nordisk
  5. 5Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity (OASIS 4) - NEJM 2025PubMed (N Engl J Med, 2025)
  6. 6Type 2 diabetes in adults: management (NG28) - recommendations on GLP-1 mimetic useNICE
  7. 7Multisociety clinical practice guidance for the safe use of GLP-1 receptor agonists in the perioperative period (2024)Clinical Gastroenterology and Hepatology
Written by Dr Chad Okay. Contributor: Dr Parisah Hussain, MBChB, BSc (Hons), DRCOG, MRCGP. Last updated . From Digests.

Related reading

All Digests

About Digests

Digests explains how the body works in general, everyday terms. It is not medical advice. It is not a substitute for someone who can examine you and knows your history, and we do not tell you what dose of any medicine to take.

Where we describe how something is checked or looked after, we follow UK guidance from NICE and the NHS, so the tests and routes where you live may differ. The same concerns are worth taking to your own doctor.

Some articles explain approaches that researchers have studied, including gut-directed hypnotherapy. Explaining an approach is education, not an offer of it: Suna does not provide hypnotherapy or any medical or psychological treatment.

Suna Health is building a wearable wellness device for gut health and offers a gut-directed relaxation app, and you will see both advertised alongside these pages. That commercial interest does not decide what the content says.

If you think we have got something wrong, tell us at digests@suna.health. It goes to the editor. Full terms, including our liability position, are at suna.health/terms.

The wearable for gut health and nutrition. Built by a passionate team, grounded in peer-reviewed research.

Suna

Suna is a wellness device, not a medical or diagnostic device. It does not diagnose, treat, cure, or prevent any disease. The Suna app offers a five-week gut-directed relaxation program for general wellbeing. The program is a self-guided wellness practice: it is not medical care, not psychological treatment, and not hypnotherapy, and it is not a substitute for care from a qualified practitioner. Information provided is general wellness information, not medical advice. Always consult a qualified healthcare professional about any health concern.

Suna Health US, Inc., 2810 N Church St STE 90849, Wilmington, DE 19802

© 2026 Suna Health.